Triple therapy of an inhaled corticosteroid, long acting β 2-agonist (LABA), and long acting muscarinic antagonist (LAMA) is more effective in reducing the annual rate of exacerbations compared with ...

Currently more than 20 inhalers are approved for the management of COPD and marketed in North America. About half are single medication inhalers and half are combination medication inhalers. This ...

Medically reviewed by Brian Bezack, DOInhaler colors often are used to identify specific types of inhalers (such as blue for ...

Let’s explore the common causes of COPD and the science behind this serious ... These fuels release harmful smoke and particles that can be inhaled over time, leading to chronic lung damage.

A recent study published in the Journal of the COPD Foundation examines errors in the use or design of inhalers used by ...

DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...

Introduction Inhaler adherence in Chronic Obstructive Pulmonary Disease (COPD) is a crucial component of disease management with studies reporting relationships with both morbidity and mortality. The ...

Objectives Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) often coexist. We assessed the effect of inhaled COPD treatments on CVD outcomes and safety in patients with ...

Poor adherence to treatment is a common issue in COPD patients and frequently results ... to partner with in the development of smart inhalers. Virtually all the companies active in the ...

while another thousand were given the most common globally used inhaler. A further 500 were given the triple combination but in two inhalers. COPD is term used to describe a number of progressive lung ...

Clinicians have been concerned whether patients with COPD can achieve sufficient inspiratory flow rates (PIFR) through DPIs due to the devices internal resistance. Aim To study PIFR through Easyhaler® ...